Janet Woodcock recently completed a long career at the FDA. She served as Director of the Center for Drug Evaluation and Research for over twenty years in several stretches. Most recently she served as Principal Deputy Commissioner and prior to that as Acting FDA Commissioner. She held multiple other senior positions at FDA including at the Center for Biologics Evaluation and Research. She was the therapeutics lead for “Operation Warp Speed” during the COVID pandemic. Her most recent effort was spearheading a major reorganization of the FDA’s foods program and the Office of Regulatory Affairs. This proposal is currently under review. Dr. Woodcock completed many major regulatory initiatives during her FDA tenure.